+44(0)1235 431390 | sales@oxfordbiosystems.com
News
News from Oxford BioSystems
Oxford BioSystems is pleased to announce our exclusive contract with Tecan UK to supply the IBL product range in the UK and Republic of Ireland.
This agreement is effective from July 2023 and we are looking forward to working with new and existing customers to introduce a variety of exciting products from IBL.
For more information, please see the attached letter. Information about the IBL products can also be found on the Tecan IBL website.
Please do not hesitate to contact us if you have any questions or would like to arrange a meeting with one of our Account Managers.
Victoria Munro, Programme Manager at Oxford BioSystems, has been part of the business for 15 years. ...
Chronic kidney disease (CKD) affects not only kidney function but also bone metabolism, creating a c...
Reliable detection of neurological biomarkers in blood and cerebrospinal fluid (CSF) remains a key c...
We recently caught up with Scott Hill, our Technical Services Lead and AID Product Specialist at Oxf...
The interleukin-2 receptor (IL-2R), also known as CD25, is a transmembrane protein, which is up-regu...
Following on from our interview with Dr Victoria Munro back in March on our commitment to reducing o...